ENB 812
Alternative Names: ENB-812Latest Information Update: 11 Dec 2023
At a glance
- Originator Engine Biosciences
- Class Antineoplastics
- Mechanism of Action PKMYT1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Colorectal cancer; Liver cancer; Lung cancer; Ovarian cancer; Prostate cancer
Most Recent Events
- 31 Oct 2023 Preclinical trials in Colorectal cancer in Singapore (unspecified route), prior to November 2023
- 31 Oct 2023 Preclinical trials in Liver cancer in Singapore (unspecified route), prior to November 2023
- 31 Oct 2023 Preclinical trials in Lung cancer in Singapore (unspecified route), prior to November 2023